Sands Capital Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sands Capital Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$120,568,860
+43149.4%
874,765
-59.3%
0.40%
-62.3%
Q4 2022$278,776
-99.9%
2,151,378
-13.3%
1.05%
+2.2%
Q3 2022$274,402,000
-1.4%
2,482,375
-33.1%
1.03%
+7.0%
Q2 2022$278,184,000
-25.5%
3,711,101
-22.4%
0.96%
+12.1%
Q1 2022$373,644,000
-22.7%
4,782,951
-10.8%
0.86%
-4.1%
Q4 2021$483,085,000
-6.2%
5,364,627
-3.6%
0.90%
+4.4%
Q3 2021$514,753,000
+18.1%
5,566,103
-0.7%
0.86%
+16.1%
Q2 2021$435,900,000
+93.1%
5,607,148
+85.2%
0.74%
+69.5%
Q1 2021$225,684,000
-32.3%
3,028,090
+54.9%
0.44%
+37.5%
Q4 2020$333,184,000
+27.2%
1,954,272
+4.8%
0.32%
-44.1%
Q3 2020$261,967,000
-62.3%
1,865,463
-57.0%
0.57%
-66.3%
Q2 2020$695,756,000
+61.5%
4,339,256
-1.4%
1.68%
+17.3%
Q1 2020$430,695,000
-26.8%
4,402,931
-3.4%
1.44%
-15.9%
Q4 2019$588,100,000
+97.6%
4,557,499
+15.3%
1.71%
+78.5%
Q3 2019$297,671,000
-44.4%
3,952,090
+12.1%
0.96%
-39.9%
Q2 2019$535,711,000
+24.3%
3,525,576
-2.5%
1.59%
+19.9%
Q1 2019$431,121,000
+27.7%
3,617,094
+16.9%
1.33%
+10.3%
Q4 2018$337,732,000
+10.0%
3,094,767
+62.7%
1.20%
+38.8%
Q3 2018$307,122,0001,901,5640.87%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders